DNCG ISO: A Solution for Asthma Prevention

Introduction

DNCG ISO is a sterile inhalation solution used to prevent asthmatic symptoms in individuals with allergic and non-allergic asthma. It is a cromolyn sodium-based medication that works by stabilizing mast cells, preventing them from releasing inflammatory mediators that contribute to asthma symptoms.

Dosage and Administration

DNCG ISO is administered via a nebulizer. The recommended dosage for adults and children over 6 years of age is 20 mg (1 ampoule) four times daily. For children 2 to 6 years of age, the recommended dosage is 10 mg (half an ampoule) four times daily. The medication should be used regularly to achieve maximum effectiveness.

Mechanism of Action

DNCG ISO works by inhibiting the degranulation of mast cells, which are immune cells that release mediators such as histamine, leukotrienes, and prostaglandins. These mediators cause inflammation and bronchospasm, leading to asthma symptoms. By stabilizing mast cells and preventing the release of these mediators, DNCG ISO helps reduce airway inflammation and improve lung function.

Side Effects

DNCG ISO is generally well-tolerated, with side effects being uncommon. The most frequent side effect is mild throat irritation, which can be minimized by rinsing the mouth after use. Other potential side effects include cough, wheezing, and nausea. If any severe side effects occur, it is important to seek medical attention.

Conclusion

DNCG ISO is an effective and safe medication for the prevention of asthma symptoms. By stabilizing mast cells and inhibiting the release of inflammatory mediators, it helps reduce airway inflammation and improve lung function. Regular use of DNCG ISO can significantly improve quality of life for individuals with asthma, allowing them to participate in activities and breathe more easily. Remember to use the medication as directed by your healthcare provider and report any side effects promptly.